In Part 4, Carolyn Krause learns more about the processes behind BWXT and LIS Technologies, which will be part of the nuclear ...
Q4 2026 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsGunnar Hansen - Director of Investor RelationsPeter Gassner ...
Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
CollectivIQ looks to give users more accurate answers to their AI queries by showing them responses that pull information ...